|
PA8849001A1
(es)
|
2008-11-21 |
2010-06-28 |
Lilly Co Eli |
Anticuerpos de c-met
|
|
EP3904391B1
(en)
|
2010-03-10 |
2024-07-10 |
Genmab A/S |
Monoclonal antibodies against c-met
|
|
US9169329B2
(en)
*
|
2010-06-01 |
2015-10-27 |
Ludwig Institute For Cancer Research |
Antibodies directed to the receptor tyrosine kinase c-Met
|
|
SG10201408229WA
(en)
|
2010-08-31 |
2015-02-27 |
Genentech Inc |
Biomarkers and methods of treatment
|
|
KR20140019284A
(ko)
*
|
2010-09-03 |
2014-02-14 |
아카데미아 시니카 |
항-C-Met 항체 및 이의 이용 방법들
|
|
EP3165538A1
(en)
|
2010-11-03 |
2017-05-10 |
Argen-X Nv |
Anti c-met antibodies
|
|
CN102276726B
(zh)
*
|
2011-03-16 |
2014-02-19 |
常州新泉生物医药科技有限公司 |
肝细胞生长因子受体活性基团的融合蛋白
|
|
US20140301989A1
(en)
*
|
2011-06-17 |
2014-10-09 |
Brian Johnstone |
Methods for increasing the potency and efficacy of stem cells
|
|
AU2012312515A1
(en)
|
2011-09-19 |
2014-03-13 |
Genentech, Inc. |
Combination treatments comprising c-met antagonists and B-raf antagonists
|
|
EP2758430A4
(en)
*
|
2011-09-20 |
2015-06-03 |
Lilly Co Eli |
ANTI-C-MET ANTIBODY
|
|
KR101865223B1
(ko)
*
|
2011-10-05 |
2018-06-08 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 인간화 항체 및 그의 용도
|
|
KR20130036993A
(ko)
*
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
ｃ-Ｍｅｔ의 ＳＥＭＡ 도메인 내의 에피토프에 특이적으로 결합하는 항체
|
|
KR20130037153A
(ko)
*
|
2011-10-05 |
2013-04-15 |
삼성전자주식회사 |
항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
EP2773660A2
(en)
|
2011-11-03 |
2014-09-10 |
Argen-X B.V. |
Chimeric human-camel antigens and their use
|
|
SG11201402485UA
(en)
|
2011-11-21 |
2014-06-27 |
Genentech Inc |
Purification of anti-c-met antibodies
|
|
WO2013079973A1
(en)
|
2011-12-02 |
2013-06-06 |
Di Cara Danielle Marie |
Antibodies against hgf - receptor and uses
|
|
CA2869316C
(en)
*
|
2012-05-09 |
2016-12-20 |
Eli Lilly And Company |
Anti-c-met antibodies
|
|
HK1208181A1
(en)
*
|
2012-06-21 |
2016-02-26 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind c-met
|
|
EP2708556B1
(en)
*
|
2012-09-12 |
2018-11-07 |
Samsung Electronics Co., Ltd |
Pharmaceutical composition for the use in a combination therapy for prevention or treatment of c-met or angiogenesis factor induced diseases
|
|
DK2839860T3
(da)
|
2012-10-12 |
2019-06-17 |
Medimmune Ltd |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
WO2014128235A1
(en)
|
2013-02-22 |
2014-08-28 |
F. Hoffmann-La Roche Ag |
Methods of treating cancer and preventing drug resistance
|
|
ES2687439T3
(es)
|
2013-03-13 |
2018-10-25 |
Medimmune Limited |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
KR102049990B1
(ko)
*
|
2013-03-28 |
2019-12-03 |
삼성전자주식회사 |
c-Met 항체 및 VEGF 결합 단편이 연결된 융합 단백질
|
|
KR102042174B1
(ko)
*
|
2013-03-29 |
2019-11-08 |
삼성전자주식회사 |
인간화 및 친화도 성숙된 항 ｃ-Ｍｅｔ 항체 및 그의 용도
|
|
EP2992019B1
(en)
*
|
2013-04-30 |
2019-03-06 |
Agency For Science, Technology And Research |
Mab 2 anti-met antibody
|
|
CN105745335A
(zh)
*
|
2013-08-14 |
2016-07-06 |
佳根曼斯菲尔德有限公司 |
用于对cMET核酸进行多模态分析的组合物及方法
|
|
US10196446B2
(en)
|
2013-10-14 |
2019-02-05 |
Janssen Biotech, Inc. |
Cysteine engineered fibronectin type III domain binding molecules
|
|
US9717715B2
(en)
|
2013-11-15 |
2017-08-01 |
Samsung Electronics Co., Ltd. |
Method of combination therapy using an anti-C-Met antibody
|
|
TW201609805A
(zh)
|
2013-12-23 |
2016-03-16 |
美國禮來大藥廠 |
結合ｅｇｆｒ及ｍｅｔ之多功能抗體
|
|
TW201622744A
(zh)
|
2014-03-04 |
2016-07-01 |
美國禮來大藥廠 |
癌症之組合療法
|
|
EP3122900A1
(en)
|
2014-03-24 |
2017-02-01 |
F. Hoffmann-La Roche AG |
Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
|
|
KR20170005016A
(ko)
|
2014-05-23 |
2017-01-11 |
제넨테크, 인크. |
MiT 바이오마커 및 그의 사용 방법
|
|
EP3193940A1
(en)
|
2014-09-10 |
2017-07-26 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
MX378108B
(es)
*
|
2014-09-16 |
2025-03-10 |
Servier Lab |
Anticuerpos anti-met y composiciones.
|
|
EP3229836B1
(en)
|
2014-12-09 |
2019-11-13 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Human monoclonal antibodies against axl
|
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
|
KR20170136536A
(ko)
|
2015-03-16 |
2017-12-11 |
셀덱스 쎄라퓨틱스, 인크. |
항-met 항체 및 그 사용 방법
|
|
US10344071B2
(en)
|
2015-07-28 |
2019-07-09 |
Musc Foundation For Research Development |
Identification of novel anti-fibrotic peptide in C-terminal region of the MET receptor tyrosine kinase
|
|
JP2019500011A
(ja)
|
2015-11-03 |
2019-01-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
腫瘍選択性及び阻害性が増強された二重特異性抗体及びその使用
|
|
CN106810611A
(zh)
*
|
2015-11-30 |
2017-06-09 |
中国科学院深圳先进技术研究院 |
抗cMet和CD3特异性双靶向抗体及其制备方法和应用、含该双靶向抗体表达盒的微环DNA及应用
|
|
EP3411067B1
(en)
|
2016-02-05 |
2021-10-20 |
Helixmith Co., Ltd |
Anti-c-met antibodies and uses thereof
|
|
GB2551372A
(en)
*
|
2016-06-16 |
2017-12-20 |
Bombardier Primove Gmbh |
A secondary unit, a system for inductive power transfer and a method for operating a secondary unit and a system for inductive power transfer
|
|
WO2017223180A2
(en)
|
2016-06-21 |
2017-12-28 |
Janssen Biotech, Inc. |
Cysteine engineered fibronectin type iii domain binding molecules
|
|
CN107556388A
(zh)
*
|
2016-06-30 |
2018-01-09 |
中国科学院深圳先进技术研究院 |
抗CD44v6和CD3特异性双靶向抗体、含该双靶向抗体表达盒的微环DNA及应用
|
|
CN107573416A
(zh)
*
|
2016-06-30 |
2018-01-12 |
中国科学院深圳先进技术研究院 |
抗igf1r和cd3特异性双靶向抗体、含该双靶向抗体表达盒的微环dna及应用
|
|
CN107556386A
(zh)
*
|
2016-06-30 |
2018-01-09 |
中国科学院深圳先进技术研究院 |
抗EGFRvIII和CD3特异性双靶向抗体、含双靶向抗体表达盒的微环DNA及应用
|
|
CN107556387A
(zh)
*
|
2016-06-30 |
2018-01-09 |
中国科学院深圳先进技术研究院 |
抗gpc3和cd3特异性双靶向抗体、含该双靶向抗体表达盒的微环dna及应用
|
|
WO2018021188A1
(ja)
*
|
2016-07-26 |
2018-02-01 |
学校法人日本大学 |
歯周炎治療薬及び歯周炎治療用組成物
|
|
US10439449B2
(en)
|
2016-08-10 |
2019-10-08 |
Microsoft Technology Licensing, Llc |
Coupling device modules for inductive data transmission
|
|
EP3519440A4
(en)
*
|
2016-09-29 |
2020-03-25 |
Mitsubishi Tanabe Pharma Corporation |
MONOCLONAL CMET BINDERS, ACTIVE SUBSTANCE CONJUGATES AND USES THEREOF
|
|
KR20230133934A
(ko)
*
|
2016-10-11 |
2023-09-19 |
아게누스 인코포레이티드 |
항-lag-3 항체 및 이의 사용 방법
|
|
CN109862919A
(zh)
|
2016-10-11 |
2019-06-07 |
免疫医疗有限公司 |
抗体-药物缀合物联合免疫介导的治疗剂
|
|
US20210283249A1
(en)
|
2016-11-16 |
2021-09-16 |
Eli Lilly And Company |
Combination therapy for cancer with exon 14 skipping mutation(s) or exon 14 skipping phenotype
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
DK3544634T3
(da)
|
2016-11-23 |
2021-06-07 |
Lilly Co Eli |
MET-antistof-lægemiddelkonjugater
|
|
WO2018111976A1
(en)
|
2016-12-14 |
2018-06-21 |
Janssen Biotech, Inc. |
Pd-l1 binding fibronectin type iii domains
|
|
WO2018111978A1
(en)
|
2016-12-14 |
2018-06-21 |
Janssen Biotech, Inc. |
Cd137 binding fibronectin type iii domains
|
|
KR102568559B1
(ko)
|
2016-12-14 |
2023-08-18 |
얀센 바이오테크 인코포레이티드 |
Cd8a-결합 섬유결합소 iii형 도메인
|
|
TW201825515A
(zh)
*
|
2017-01-04 |
2018-07-16 |
美商伊繆諾金公司 |
Ｍｅｔ抗體以及其免疫結合物及用途
|
|
CN106986932A
(zh)
*
|
2017-04-06 |
2017-07-28 |
海口市人民医院 |
一种c‑Met表位肽及其应用
|
|
EP3630844A4
(en)
*
|
2017-05-30 |
2021-03-03 |
Chong Kun Dang Pharmaceutical Corp. |
NOVEL ANTI-C-MET ANTIBODY AND USE OF IT
|
|
CN109771642B
(zh)
*
|
2017-11-13 |
2022-09-20 |
同济大学苏州研究院 |
c-MET激动型抗体及其用途
|
|
GB201803892D0
(en)
|
2018-03-12 |
2018-04-25 |
Ultrahuman Six Ltd |
C-met binding agents
|
|
CA3098103A1
(en)
|
2018-05-23 |
2019-11-28 |
Adc Therapeutics Sa |
Molecular adjuvant
|
|
CN114340684B
(zh)
|
2019-09-16 |
2025-09-12 |
瑞泽恩制药公司 |
用于免疫pet成像的放射性标记的met结合蛋白
|
|
US11781138B2
(en)
|
2019-10-14 |
2023-10-10 |
Aro Biotherapeutics Company |
FN3 domain-siRNA conjugates and uses thereof
|
|
WO2021076543A1
(en)
|
2019-10-14 |
2021-04-22 |
Aro Biotherapeutics Company |
Epcam binding fibronectin type iii domains
|
|
CN114786682B
(zh)
|
2019-10-14 |
2024-07-16 |
Aro生物疗法公司 |
结合cd71的纤维粘连蛋白iii型结构域
|
|
JP7510518B2
(ja)
|
2020-09-01 |
2024-07-03 |
レメゲン シーオー．，エルティーディー． |
抗ｃ－Ｍｅｔ抗体薬物複合体及びその応用
|
|
US20230372528A1
(en)
|
2020-10-16 |
2023-11-23 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
|
CN117529499A
(zh)
*
|
2021-02-03 |
2024-02-06 |
神话治疗股份有限公司 |
抗met抗体和其用途
|
|
GB202102396D0
(en)
|
2021-02-19 |
2021-04-07 |
Adc Therapeutics Sa |
Molecular adjuvant
|
|
AU2022254291A1
(en)
|
2021-04-08 |
2023-10-12 |
Byondis B.V. |
Anti-c-met antibodies and antibody-drug conjugates
|
|
JP2024517610A
(ja)
|
2021-04-14 |
2024-04-23 |
アロ・バイオセラピューティクス・カンパニー |
Ｃｄ７１に結合するフィブロネクチンｉｉｉ型ドメイン
|
|
KR20240031947A
(ko)
|
2021-04-14 |
2024-03-08 |
에이알오 바이오테라퓨틱스 컴패니 |
Fn3 도메인-시르나 접합체 및 이의 용도
|
|
CN113788895B
(zh)
*
|
2021-10-14 |
2023-09-15 |
陕西健吉跃生物科技有限公司 |
一种兔多克隆抗体及其制备方法和应用
|
|
CN117980327A
(zh)
|
2021-11-03 |
2024-05-03 |
杭州多禧生物科技有限公司 |
抗体的特异性偶联
|
|
AU2024277829A1
(en)
|
2023-05-19 |
2025-12-04 |
Les Laboratoires Servier |
Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof
|
|
CN121969654A
(zh)
*
|
2023-08-02 |
2026-05-01 |
百泰生物药业有限公司 |
EGFR/c-Met双特异性抗体及其应用
|